Leaflet CRIXIVAN 200mg capsules

Product code:
W03593002
Quantity:
270
Indicated for:
HIV-1 infection
Route of administration:
oral
Substance:
indinavir (protease inhibitor)
ATC
J05AE02 — Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Precautions:

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning

Use during pregnancy only on medical advice.

Indinavir is an antiretroviral medication used to treat human immunodeficiency virus (HIV) infection. It belongs to the class of protease inhibitors and works by blocking the HIV protease enzyme, which is essential for viral replication.

The medication is taken orally, usually three times a day, as directed by a doctor.

Side effects may include nausea, abdominal pain, diarrhea, dry mouth, or kidney stone formation. In rare cases, severe allergic reactions or changes in body fat distribution may occur.

Patients should strictly follow the treatment regimen and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about CRIXIVAN 200mg

Substance:
indinavir
Date of latest medicines list:
01-07-2013
Product code:
W03593002
Concentration:
200mg
Pharmaceutical form:
capsules
Quantity:
270
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Concentrations available for indinavir

  • 100mg
  • 200mg
  • 333mg
  • 400mg